Commentary

Cases of liver failure linked to “fat-burning” supplement


 

References

In late 2013, there were 45 cases of acute liver failure (ALF) in Hawaii, and 29 of those people reported taking OxyELITE Pro (an herbal dietary supplement marketed for weight reduction and “fat-burning”) 60 days before illness onset. Of 8 initial cases, 2 patients needed urgent liver transplants, one died, and 5 eventually recovered.1 The manufacturer of OxyELITE Pro voluntarily recalled the product after receiving a warning letter from the US Food and Drug Administration (FDA).

One way to prevent situations like this from occurring might be to ban the sale of weight loss or sports enhancement supplements unless they are rigorously tested and approved by the FDA. Voluntary reporting to the FDA is time-consuming and it takes time for the FDA to follow up on these reports.

As primary care physicians, we need to consistently ask patients about their use of supplements, educate them about the potential dangers, and identify those who are experiencing adverse reactions. While we can’t put a stop to the harm that some herbal dietary supplements might inflict on a public eager to embrace quick fixes for weight loss and improved strength, we can be the best first responders.

Linda L. Wong, MD
Honolulu, Hawaii

Recommended Reading

Cirrhosis complications: Keeping them under control
MDedge Family Medicine
Managing dyspepsia
MDedge Family Medicine
VIDEO: Nivolumab puts brakes on advanced liver cancer
MDedge Family Medicine
Teaching patients about Hepatitis C
MDedge Family Medicine
Online resource provides updated HCV tx guidelines
MDedge Family Medicine
CDC guidance on hepatitis C counseling and testing
MDedge Family Medicine
FDA approves Daklinza for HCV genotype 3 infections
MDedge Family Medicine
FDA approves oral interferon-free treatment for genotype 4 HCV infection
MDedge Family Medicine
Hepatitis C: How to fine-tune your approach
MDedge Family Medicine
Umbilical hernia in a patient with cirrhosis
MDedge Family Medicine